Brief: Oncosil Medical Seeks Trading Halt
16/09/2025 23:52
Sept 17 (Reuters) - Oncosil Medical Ltd OSL.AX: TRADING HALT REQUESTED PENDING PANCOSIL TRIAL RESULTS Further company coverage: OSL.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncosil Medical
See all newsAustralia's OncoSil Medical gains most in over 2 months on reaching 100-th patient milestone
Brief: Oncosil Medical Says FDA Grants Hde Approval For Oncosil Device For Distal Cholangiocarcinoma
Brief: Oncosil Medical Posts FY26 Unit Sales Up 53%, Revenue Up 44% Versus FY25
Brief: Oncosil Medical Receives Saudi FDA Approval
Brief: Oncosil Medical Files For FDA Approval